These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32327176)

  • 21. Lung Cancer: Management.
    Mott TF
    FP Essent; 2018 Jan; 464():27-30. PubMed ID: 29313655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy.
    Reungwetwattana T; Eadens MJ; Molina JR
    Semin Respir Crit Care Med; 2011 Feb; 32(1):78-93. PubMed ID: 21500127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Jiang Y; Liu LS; Shen LP; Liu JX; Jiang GN; Gu AQ; Li HC; Li Q; Li HG; Huang PX
    Clin Lung Cancer; 2019 Sep; 20(5):e541-e547. PubMed ID: 31230892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined modality treatment of non-small-cell lung cancer.
    Westeel V; Depierre A
    Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of non-small cell lung carcinoma].
    Souquet PJ
    Rev Prat; 2003 Apr; 53(7):747-51. PubMed ID: 12879798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
    Choong NW; Vokes EE
    Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S98-104. PubMed ID: 16384544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    Drake JA; Sullivan JL; Weksler B
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1794-1802. PubMed ID: 29352585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease.
    Smithy JW; Rosen JE; Gao SJ; Kim AW
    J Surg Oncol; 2017 Dec; 116(8):1193-1196. PubMed ID: 29314062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?
    Konopa K
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii199-202. PubMed ID: 20943615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS; Curran WJ
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NCCN: Non-small cell lung cancer.
    Ettinger DS; Kris MG;
    Cancer Control; 2001; 8(6 Suppl 2):22-31. PubMed ID: 11760555
    [No Abstract]   [Full Text] [Related]  

  • 35. Ongoing clinical trials in lung cancer.
    Giaccone G; Tonato M
    Eur J Surg Oncol; 1996 Feb; 22(1):4-9. PubMed ID: 8846865
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant and neoadjuvant therapy for stages I through III non-small cell lung cancer.
    Rusch VW
    Ann Thorac Surg; 1994 Sep; 58(3):899-900. PubMed ID: 7944732
    [No Abstract]   [Full Text] [Related]  

  • 37. Principles of Immunotherapy in Non-Small Cell Lung Cancer.
    Hsu ML; Naidoo J
    Thorac Surg Clin; 2020 May; 30(2):187-198. PubMed ID: 32327177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimising treatment for post-operative lung cancer recurrence.
    Subotic D; Van Schil P; Grigoriu B
    Eur Respir J; 2016 Feb; 47(2):374-8. PubMed ID: 26828046
    [No Abstract]   [Full Text] [Related]  

  • 39. Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
    Bunn PA; Kim ES
    Clin Lung Cancer; 2015 Jul; 16(4):245-51. PubMed ID: 25887065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of lung cancer.
    Gadgeel SM; Ramalingam SS; Kalemkerian GP
    Radiol Clin North Am; 2012 Sep; 50(5):961-74. PubMed ID: 22974781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.